Biogen And Alzheimer’s Disease: Closer To Resolution
Sean Pavone/iStock via Getty Images
The Food and Drug Administration has partially reversed itself and decided to restrict the use of Biogen’s (BIIB) drug Aduhelm to patients with mild cognitive impairment or early Alzheimer’s disease. The FDA, under heavy…
